Clinical trial

Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer

NCT00003517

Drugs and interventions used in this trial

14 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention antineoplaston A10 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention antineoplaston AS2-1 Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record bicalutamide Normalized identity: bicalutamideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record flutamide Normalized identity: flutamideView linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record leuprolide acetate Normalized identity: leuprolide acetateView linked drug · Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention alternative product therapy Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention antiandrogen therapy Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention biological therapy Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention biologically based therapies Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention cancer prevention intervention Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention complementary and alternative therapy Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention differentiation therapy Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention endocrine therapy Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention hormone therapy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start dateUnknown

PhasePHASE2

Conditions

Adenocarcinoma of the Prostateverified · MONDO: prostate adenocarcinoma

Stage III Prostate Cancerunresolved

Stage IV Prostate Cancerunresolved

Recurrent Prostate Cancerunresolved

Interventions

antineoplaston A10DRUG

antineoplaston AS2-1DRUG

bicalutamideDRUG · verified · RxNorm: bicalutamide

flutamideDRUG · verified · RxNorm: flutamide

leuprolide acetateDRUG · verified · RxNorm: leuprolide acetate

alternative product therapyPROCEDURE

antiandrogen therapyPROCEDURE

biological therapyPROCEDURE

biologically based therapiesPROCEDURE

cancer prevention interventionPROCEDURE

complementary and alternative therapyPROCEDURE

differentiation therapyPROCEDURE

endocrine therapyPROCEDURE

hormone therapyPROCEDURE

Sponsors & collaborators

Burzynski Research Institutelead sponsor

Mapped research locations

HoustonTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00003517 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.